Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 161-170 of 444 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. Study Of RAS(ON) Inhibitors In Patients With Gastrointestinal Solid Tumors

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A First-in-Human Study Of MEN2312 In Adults With Advanced Breast Cancer

    Rochester, MN

  3. A Study To Evaluate The Efficacy Of Cemsidomide + Dexamethasone In Participants With Relapsed/Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. A Study To Investigate The Safety And Tolerability Of Ziftomenib In Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, Or 7+3+Quizartinib In Patients With AML

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. ASPEN-09: A Study Of Evorpacept In Combination With Anti-cancer Therapies In Advanced / Metastatic Malignancies

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. Methotrexate, Erlotinib, And Celecoxib For The Treatment Of Recurrent/Metastatic Oral Cavity Cancer In A Rural Midwest United States Population

    Albert Lea, MN, La Crosse, WI, Rochester, MN

  7. Neoadjuvant Dual Checkpoint Blockade With PD1 And LAG-3 Inhibition In Resectable Non-small Cell Lung Cancer

    Jacksonville, FL, Rochester, MN

  8. Testing The Addition Of Duvelisib Or CC-486 To The Usual Treatment For Peripheral T-Cell Lymphoma

    Rochester, MN

  9. Virtual Reality Intervention To Improve Psychological Symptom Burden For Cancer Patients Undergoing Treatment

    Jacksonville, FL

  10. Eliminating Breast Cancer Surgery In Exceptional Responders With Neoadjuvant Systemic Therapy

    Rochester, MN

.

Mayo Clinic Footer